Mr. McBrayer currently serves as president and CEO of AxioMed Spine, a developer of next-generation technology for degenerative spine conditions. He previously served as president and CEO of Osteotech, a provider of tissue technology.
More articles on devices:
37 spine, orthopedic devices receive FDA 510(k) clearance in September
Nevro files IPO — 6 things to know
BD buys CareFusion for $12.2B: 8 things to know
